glp-1 news 2025 october 21 Repurposing glucagon-like peptide-1 receptor agonists for the treatment of neurodegenerative disorders GLP-1 Pharmacy Pricing Update (Dec

Theoretically, combining it with cagrilintide could provide triple-mechanism coverage: amylin receptor activation (cagrilintide) plus GIP and GLP-1 receptor activation (tirzepatide)

Lancet Haematology 2026

A randomized, double-blind, placebo-controlled, 12-week trial of vitamin D augmentation in major depressive disorder associated with vitamin D deficiency

Longo M, Zatterale F, Naderi J, et al

Look for materials like heavy-duty leather or Biothane

Svegliati-Baroni G, Saccomanno S, Rychlicki C, Agostinelli L, De Minicis S, Candelaresi C, Faraci G, Pacetti D, Vivarelli M, Nicolini D, Garelli P, Casini A, Manco M, Mingrone G, Risaliti A, Frega GN, Benedetti A, Gastaldelli A